Neuroimmune mechanisms of depression

Nature Neuroscience

Volumn 18, Issue 10, 2015, Pages 1386-1393

  Hodes, Georgia E ^a   Kana, Veronika ^a   Menard, Caroline ^a   Merad, Miriam ^a   Russo, Scott J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

BRAIN CELL; DEPRESSION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MAJOR DEPRESSION; META ANALYSIS (TOPIC); NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; ANIMAL; BRAIN; IMMUNOLOGY; IMMUNOMODULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; BRAIN; DEPRESSION; HUMANS; NEUROIMMUNOMODULATION;

EID: 84942427794     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.4113     Document Type: Review

References (115)

1. Maes, M. et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 34, 301-309 (1995)
2. Dowlati, Y. et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446-457 (2010)
3. Hodes, G.E. et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc. Natl. Acad. Sci. USA 111, 16136-16141 (2014)
4. Maes, M. et al. Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. J. Psychiatr. Res. 26, 125-134 (1992)
5. Fenton, W.S. &Stover, E.S. Mood disorders: cardiovascular and diabetes comorbidity. Curr. Opin. Psychiatry 19, 421-427 (2006)
6. Maes, M., Kubera, M., Obuchowiczwa, E., Goehler, L. &Brzeszcz, J. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative &nitrosative stress pathways. Neuroendocrinol. Lett. 32, 7-24 (2011)
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn. (American Psychiatric Association, Arlington, Virginia, 2013)
8. Krishnan, V. &Nestler, E.J. The molecular neurobiology of depression. Nature 455, 894-902 (2008)
9. Renault, P.F. et al. Psychiatric complications of long-term interferon alfa therapy. Arch. Intern. Med. 147, 1577-1580 (1987)
10. Conversano, C. et al. Interferon alpha therapy in patients with chronic hepatitis C infection: quality of life and depression. Hematol. Rep. 7, 5632 (2015)
11. Maes, M. et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9, 853-858 (1997)
12. Miller, G.E. et al. Greater inflammatory activity and blunted glucocorticoid signaling in monocytes of chronically stressed caregivers. Brain Behav. Immun. 41, 191-199 (2014)
13. Khandaker, G.M., Pearson, R.M., Zammit, S., Lewis, G. &Jones, P.B. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71, 1121-1128 (2014)
14. Raison, C.L. et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70, 31-41 (2013)
15. Venkiteshwaran, A. Tocilizumab. MAbs 1, 432-438 (2009)
16. Brietzke, E., Scheinberg, M. &Lafer, B. Therapeutic potential of interleukin-6 antagonism in bipolar disorder. Med. Hypotheses 76, 21-23 (2011)
17. Langley, R.G. et al. Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. J. Am. Acad. Dermatol. 63, 457-465 (2010)
18. Iyengar, R.L. et al. NSAIDs are associated with lower depression scores in patients with osteoarthritis. Am. J. Med. 126, e1011-e1018 (2013)
19. Köhler, O. et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71, 1381-1391 (2014)
20. Eyre, H.A., Air, T., Proctor, S., Rositano, S. &Baune, B.T. A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 57, 11-16 (2015)
21. Warner-Schmidt, J.L., Vanover, K.E., Chen, E.Y., Marshall, J.J. &Greengard, P. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc. Natl. Acad. Sci. USA 108, 9262-9267 (2011)
22. Słuzewska, A. et al. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. NY Acad. Sci. 762, 474-476 (1995)
23. Jazayeri, S. et al. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder. Psychiatry Res. 178, 112-115 (2010)
24. Kubera, M. et al. Stimulatory effect of antidepressants on the production of IL-6. Int. Immunopharmacol. 4, 185-192 (2004)
25. Murrough, J.W. et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am. J. Psychiatry 170, 1134-1142 (2013)
26. De Kock, M., Loix, S. &Lavand'homme, P. Ketamine and peripheral inflammation. CNS Neurosci. Ther. 19, 403-410 (2013)
27. Scheiermann, C., Frenette, P.S. &Hidalgo, A. Regulation of leucocyte homeostasis in the circulation. Cardiovasc. Res. 107, 340-351 (2015)
28. Hashimoto, D., Miller, J. &Merad, M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 35, 323-335 (2011)
29. Spits, H. et al. Innate lymphoid cells-A proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013)
30. Frank, M.G., Weber, M.D., Watkins, L.R. &Maier, S.F. Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav. Immun. 48, 1-7 (2015)
31. Portou, M.J., Baker, D., Abraham, D. &Tsui, J. The innate immune system, toll-like receptors and dermal wound healing: a review. Vascul. Pharmacol. 71, 31-36 (2015)
32. Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994)
33. Raz, E. Organ-specific regulation of innate immunity. Nat. Immunol. 8, 3-4 (2007)
34. Marino, F. &Cosentino, M. Adrenergic modulation of immune cells: an update. Amino Acids 45, 55-71 (2013)
35. Amsterdam, A., Tajima, K. &Sasson, R. Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem. Pharmacol. 64, 843-850 (2002)
36. Rosas-Ballina, M. et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98-101 (2011)
37. Tracey, K.J. Reflex control of immunity. Nat. Rev. Immunol. 9, 418-428 (2009)
38. Avitsur, R., Powell, N., Padgett, D.A. &Sheridan, J.F. Social interactions, stress, and immunity. Immunol. Allergy Clin. North Am. 29, 285-293 (2009)
39. Engler, H. et al. Interleukin-1 receptor type 1-deficient mice fail to develop social stress-associated glucocorticoid resistance in the spleen. Psychoneuroendocrinology 33, 108-117 (2008)
40. Frank, M.G., Watkins, L.R. &Maier, S.F. Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger. Brain Behav. Immun. 33, 1-6 (2013)
41. Manz, M.G. &Boettcher, S. Emergency granulopoiesis. Nat. Rev. Immunol. 14, 302-314 (2014)
42. Ginhoux, F. &Jung, S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14, 392-404 (2014)
43. Nakai, A., Hayano, Y., Furuta, F., Noda, M. &Suzuki, K. Control of lymphocyte egress from lymph nodes through beta2-adrenergic receptors. J. Exp. Med. 211, 2583-2598 (2014)
44. Ransohoff, R.M. &Brown, M.A. Innate immunity in the central nervous system. J. Clin. Invest. 122, 1164-1171 (2012)
45. Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845 (2010)
46. Ajami, B., Bennett, J.L., Krieger, C., Tetzlaff, W. &Rossi, F.M. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10, 1538-1543 (2007)
47. Greter, M. et al. Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity 37, 1050-1060 (2012)
48. Nandi, S. et al. The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev. Biol. 367, 100-113 (2012)
49. Shechter, R., London, A. &Schwartz, M. Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat. Rev. Immunol. 13, 206-218 (2013)
50. Bulloch, K. et al. CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J. Comp. Neurol. 508, 687-710 (2008)
51. Baruch, K. &Schwartz, M. CNS-specific T cells shape brain function via the choroid plexus. Brain Behav. Immun. 34, 11-16 (2013)
52. Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337-341 (2015)
53. Nimmerjahn, A., Kirchhoff, F. &Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318 (2005)
54. Stevens, B. et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164-1178 (2007)
55. Paolicelli, R.C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456-1458 (2011)
56. Limatola, C. &Ransohoff, R.M. Modulating neurotoxicity through CX3CL1/CX3CR1 signaling. Front. Cell. Neurosci. 8, 229 (2014)
57. Ajami, B., Bennett, J.L., Krieger, C., McNagny, K.M. &Rossi, F.M. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14, 1142-1149 (2011)
58. Yamasaki, R. et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J. Exp. Med. 211, 1533-1549 (2014)
59. Wohleb, E.S., Powell, N.D., Godbout, J.P. &Sheridan, J.F. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J. Neurosci. 33, 13820-13833 (2013)
60. Sawicki, C.M. et al. Social defeat promotes a reactive endothelium in a brain region-dependent manner with increased expression of key adhesion molecules, selectins and chemokines associated with the recruitment of myeloid cells to the brain. Neuroscience 302, 151-164 (2015)
61. Hickman, S.E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896-1905 (2013)
62. Maes, M. Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 19, 11-38 (1995)
63. Smith, R.S. The macrophage theory of depression. Med. Hypotheses 35, 298-306 (1991)
64. Heidt, T. et al. Chronic variable stress activates hematopoietic stem cells. Nat. Med. 20, 754-758 (2014)
65. Brachman, R.A., Lehmann, M.L., Maric, D. &Herkenham, M. Lymphocytes from chronically stressed mice confer antidepressant-like effects to naive mice. J. Neurosci. 35, 1530-1538 (2015)
66. Pariante, C.M. The glucocorticoid receptor: part of the solution or part of the problem? J. Psychopharmacol. 20, 79-84 (2006)
67. Quan, N. et al. Molecular mechanisms of glucocorticoid resistance in splenocytes of socially stressed male mice. J. Neuroimmunol. 137, 51-58 (2003)
68. Kollet, O. et al. Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors. Leukemia 27, 2006-2015 (2013)
69. Banks, W.A., Kastin, A.J. &Gutierrez, E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 179, 53-56 (1994)
70. Banks, W.A., Kastin, A.J. &Broadwell, R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2, 241-248 (1995)
71. Gadient, R.A. &Otten, U.H. Interleukin-6 (IL-6)-A molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52, 379-390 (1997)
72. Gordon, S. &Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964 (2005)
73. Reader, B.F. et al. Peripheral and central effects of repeated social defeat stress: monocyte trafficking, microglial activation, and anxiety. Neuroscience 289, 429-442 (2015)
74. Gudmundsson, P. et al. The relationship between cerebrospinal fluid biomarkers and depression in elderly women. Am. J. Geriatr. Psychiatry 15, 832-838 (2007)
75. Torres-Platas, S.G., Cruceanu, C., Chen, G.G., Turecki, G. &Mechawar, N. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav. Immun. 42, 50-59 (2014)
76. Varvel, N.H. et al. Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells. Proc. Natl. Acad. Sci. USA 109, 18150-18155 (2012)
77. Diniz, B.S., Butters, M.A., Albert, S.M., Dew, M.A. &Reynolds, C.F. III. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br. J. Psychiatry 202, 329-335 (2013)
78. El Khoury, J. et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432-438 (2007)
79. Wang, D.D. &Bordey, A. The astrocyte odyssey. Prog. Neurobiol. 86, 342-367 (2008)
80. Meeuwsen, S., Persoon-Deen, C., Bsibsi, M., Ravid, R. &van Noort, J.M. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43, 243-253 (2003)
81. Pang, Y., Cai, Z. &Rhodes, P.G. Analysis of genes differentially expressed in astrocytes stimulated with lipopolysaccharide using cDNA arrays. Brain Res. 914, 15-22 (2001)
82. Nagy, C. et al. Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol. Psychiatry 20, 320-328 (2015)
83. Leventopoulos, M. et al. Long-term effects of early life deprivation on brain glia in Fischer rats. Brain Res. 1142, 119-126 (2007)
84. Tynan, R.J. et al. Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes. Acta Neuropathol. 126, 75-91 (2013)
85. Steiner, J. et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J. Neuroinflammation 8, 94 (2011)
86. Steiner, J. et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 42, 151-157 (2008)
87. Setiawan, E. et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72, 268-275 (2015)
88. Frank, M.G., Baratta, M.V., Sprunger, D.B., Watkins, L.R. &Maier, S.F. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav. Immun. 21, 47-59 (2007)
89. Wohleb, E.S. et al. Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 31, 6277-6288 (2011)
90. Frank, M.G., Miguel, Z.D., Watkins, L.R. &Maier, S.F. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav. Immun. 24, 19-30 (2010)
91. Meagher, M.W. et al. Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection. Brain Behav. Immun. 21, 1083-1095 (2007)
92. Koo, J.W., Russo, S.J., Ferguson, D., Nestler, E.J. &Duman, R.S. Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl. Acad. Sci. USA 107, 2669-2674 (2010)
93. Koo, J.W. &Duman, R.S. IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl. Acad. Sci. USA 105, 751-756 (2008)
94. Monje, F.J. et al. Constant darkness induces IL-6-dependent depression-like behavior through the NF-κB signaling pathway. J. Neurosci. 31, 9075-9083 (2011)
95. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W. &Kelley, K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46-56 (2008)
96. Maes, M., Leonard, B.E., Myint, A.M., Kubera, M. &Verkerk, R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 702-721 (2011)
97. Garcia-Oscos, F. et al. The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling. Biol. Psychiatry 71, 574-582 (2012)
98. Beattie, E.C. et al. Control of synaptic strength by glial TNF and alpha;. Science 295, 2282-2285 (2002)
99. Rolls, A. et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 9, 1081-1088 (2007)
100. Santarelli, L. et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809 (2003)
101. Kettenmann, H., Kirchhoff, F. &Verkhratsky, A. Microglia: new roles for the synaptic stripper. Neuron 77, 10-18 (2013)
102. Hawkes, C.A. &McLaurin, J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc. Natl. Acad. Sci. USA 106, 1261-1266 (2009)
103. Leinenga, G. &Gotz, J. Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model. Sci. Transl. Med. 7, 278ra233 (2015)
104. Chen, S.K. et al. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 141, 775-785 (2010)
105. Lin, S. et al. Comparison of the transcriptional landscapes between human and mouse tissues. Proc. Natl. Acad. Sci. USA 111, 17224-17229 (2014)
106. Mestas, J. &Hughes, C.C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731-2738 (2004)
107. Maes, M. et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10, 313-318 (1998)
108. Bluthé, R.M., Dantzer, R. &Kelley, K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 573, 318-320 (1992)
109. Willner, P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90-110 (2005)
110. Dalla, C., Pitychoutis, P.M., Kokras, N. &Papadopoulou-Daifoti, Z. Sex differences in animal models of depression and antidepressant response. Basic Clin. Pharmacol. Toxicol. 106, 226-233 (2010)
111. Krishnan, V., Berton, O. &Nestler, E. The use of animal models in psychiatric research and treatment. Am. J. Psychiatry 165, 1109 (2008)
112. Yang, C., Shirayama, Y., Zhang, J.C., Ren, Q. &Hashimoto, K. Peripheral interleukin-6 promotes resilience versus susceptibility to inescapable electric stress. Acta Neuropsychiatr. 2015, 1-5 (2015)
113. Slattery, D.A. &Cryan, J.F. The ups and downs of modelling mood disorders in rodents. ILAR J. 55, 297-309 (2014)
114. Golden, S.A., Covington, H.E. III, Berton, O. &Russo, S.J. A standardized protocol for repeated social defeat stress in mice. Nat. Protoc. 6, 1183-1191 (2011)
115. Berton, O. et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311, 864-868 (2006)